In order to explore the changes of clinical parameters and prevalence of NAFLD under different RCAN2 concentration gradients in all study subjects, serum RCAN2 levels were divided into tertiles. The gene discussed is RCAN2; the disease is metabolic dysfunction-associated steatotic liver disease.